 Iain Konigsberg
Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Disease, Chronic Obstructive | 4 | 2026 | 923 | 1.190 |
Why?
| | DNA Methylation | 8 | 2025 | 683 | 1.070 |
Why?
| | Genome-Wide Association Study | 9 | 2026 | 1407 | 1.010 |
Why?
| | Sarcoidosis, Pulmonary | 2 | 2024 | 95 | 0.900 |
Why?
| | Body Mass Index | 5 | 2026 | 2438 | 0.820 |
Why?
| | Multifactorial Inheritance | 6 | 2026 | 203 | 0.770 |
Why?
| | Idiopathic Pulmonary Fibrosis | 4 | 2025 | 691 | 0.750 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2024 | 636 | 0.740 |
Why?
| | Gene Expression | 4 | 2022 | 1490 | 0.700 |
Why?
| | Smoking | 2 | 2024 | 1472 | 0.640 |
Why?
| | Proteomics | 3 | 2026 | 1195 | 0.590 |
Why?
| | Sarcoidosis | 1 | 2021 | 160 | 0.590 |
Why?
| | RNA, Long Noncoding | 1 | 2021 | 178 | 0.590 |
Why?
| | Obesity | 5 | 2026 | 3082 | 0.560 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 2 | 2025 | 88 | 0.430 |
Why?
| | Transcriptome | 1 | 2021 | 1046 | 0.430 |
Why?
| | Lung Diseases | 1 | 2021 | 787 | 0.420 |
Why?
| | Polymorphism, Single Nucleotide | 7 | 2025 | 2147 | 0.420 |
Why?
| | Whole Genome Sequencing | 2 | 2025 | 183 | 0.410 |
Why?
| | Quantitative Trait Loci | 3 | 2025 | 374 | 0.410 |
Why?
| | Genetic Predisposition to Disease | 7 | 2026 | 2365 | 0.390 |
Why?
| | Epigenesis, Genetic | 5 | 2025 | 685 | 0.380 |
Why?
| | Lung | 3 | 2025 | 4109 | 0.370 |
Why?
| | Genetic Variation | 3 | 2025 | 984 | 0.340 |
Why?
| | Macrophages | 3 | 2025 | 1511 | 0.330 |
Why?
| | Genomics | 2 | 2025 | 836 | 0.310 |
Why?
| | Phenotype | 5 | 2025 | 3164 | 0.300 |
Why?
| | Atherosclerosis | 2 | 2023 | 409 | 0.290 |
Why?
| | Asthma | 1 | 2020 | 1768 | 0.290 |
Why?
| | Berylliosis | 2 | 2022 | 202 | 0.280 |
Why?
| | Weight Loss | 2 | 2026 | 837 | 0.270 |
Why?
| | Humans | 33 | 2026 | 144957 | 0.260 |
Why?
| | Gene Expression Profiling | 4 | 2024 | 1786 | 0.260 |
Why?
| | Case-Control Studies | 3 | 2024 | 3608 | 0.240 |
Why?
| | Middle Aged | 13 | 2026 | 35928 | 0.230 |
Why?
| | RNA, Messenger | 2 | 2024 | 2832 | 0.220 |
Why?
| | Genetics, Population | 1 | 2025 | 215 | 0.200 |
Why?
| | Particle Size | 1 | 2025 | 411 | 0.200 |
Why?
| | Phagocytosis | 1 | 2025 | 299 | 0.200 |
Why?
| | Cholesterol, LDL | 1 | 2025 | 358 | 0.200 |
Why?
| | Male | 17 | 2026 | 72406 | 0.200 |
Why?
| | Respiratory Tract Diseases | 1 | 2024 | 175 | 0.190 |
Why?
| | Female | 17 | 2026 | 78376 | 0.180 |
Why?
| | Aged | 9 | 2026 | 25947 | 0.180 |
Why?
| | Fetal Blood | 1 | 2024 | 342 | 0.180 |
Why?
| | Mortality | 1 | 2024 | 376 | 0.180 |
Why?
| | Social Determinants of Health | 1 | 2026 | 301 | 0.170 |
Why?
| | Salmonella | 1 | 2022 | 61 | 0.170 |
Why?
| | Matrix Metalloproteinase 7 | 1 | 2021 | 25 | 0.170 |
Why?
| | Methylation | 1 | 2022 | 242 | 0.170 |
Why?
| | Salmonella enterica | 1 | 2022 | 59 | 0.170 |
Why?
| | Overweight | 1 | 2026 | 609 | 0.170 |
Why?
| | Diabetes, Gestational | 1 | 2025 | 321 | 0.170 |
Why?
| | Granuloma | 1 | 2021 | 96 | 0.160 |
Why?
| | Tumor Microenvironment | 1 | 2025 | 735 | 0.160 |
Why?
| | Frailty | 1 | 2023 | 198 | 0.160 |
Why?
| | Disease Progression | 2 | 2026 | 2852 | 0.160 |
Why?
| | Alveolitis, Extrinsic Allergic | 1 | 2020 | 93 | 0.150 |
Why?
| | Weight Reduction Programs | 1 | 2021 | 137 | 0.150 |
Why?
| | Gastrointestinal Microbiome | 2 | 2026 | 771 | 0.150 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2025 | 653 | 0.140 |
Why?
| | Proteome | 1 | 2023 | 518 | 0.140 |
Why?
| | Biomarkers | 4 | 2024 | 4275 | 0.140 |
Why?
| | MicroRNAs | 1 | 2024 | 701 | 0.130 |
Why?
| | Sex Characteristics | 1 | 2023 | 791 | 0.130 |
Why?
| | Behavior Therapy | 1 | 2021 | 299 | 0.130 |
Why?
| | Adult | 7 | 2026 | 40506 | 0.130 |
Why?
| | Insulin Resistance | 1 | 2025 | 1241 | 0.120 |
Why?
| | Genome, Human | 3 | 2025 | 422 | 0.120 |
Why?
| | Hypertension | 1 | 2025 | 1264 | 0.120 |
Why?
| | Environmental Exposure | 1 | 2021 | 590 | 0.120 |
Why?
| | Microbiota | 1 | 2023 | 781 | 0.110 |
Why?
| | Lung Diseases, Interstitial | 1 | 2020 | 660 | 0.100 |
Why?
| | Risk Factors | 5 | 2026 | 10792 | 0.100 |
Why?
| | Epigenomics | 2 | 2024 | 114 | 0.100 |
Why?
| | Cardiovascular Diseases | 1 | 2024 | 2171 | 0.090 |
Why?
| | Child | 4 | 2025 | 22657 | 0.090 |
Why?
| | Genotype | 2 | 2025 | 1835 | 0.080 |
Why?
| | Gene Expression Regulation | 1 | 2019 | 2609 | 0.070 |
Why?
| | HIV Infections | 1 | 2023 | 3154 | 0.070 |
Why?
| | RNA | 2 | 2022 | 940 | 0.060 |
Why?
| | Mississippi | 1 | 2025 | 29 | 0.060 |
Why?
| | CpG Islands | 1 | 2025 | 165 | 0.060 |
Why?
| | Adoptive Transfer | 1 | 2025 | 198 | 0.050 |
Why?
| | Chemotaxis | 1 | 2025 | 122 | 0.050 |
Why?
| | Chronic Disease | 2 | 2022 | 1813 | 0.050 |
Why?
| | Protein Interaction Maps | 1 | 2024 | 51 | 0.050 |
Why?
| | Drug Repositioning | 1 | 2024 | 41 | 0.050 |
Why?
| | Gene-Environment Interaction | 1 | 2026 | 180 | 0.050 |
Why?
| | Adolescent | 4 | 2025 | 22453 | 0.050 |
Why?
| | Glucose Tolerance Test | 1 | 2025 | 361 | 0.050 |
Why?
| | Bone Marrow Cells | 1 | 2025 | 320 | 0.050 |
Why?
| | Normal Distribution | 1 | 2023 | 22 | 0.050 |
Why?
| | Privacy | 1 | 2023 | 41 | 0.050 |
Why?
| | Desmoplakins | 1 | 2022 | 24 | 0.050 |
Why?
| | Bronchoalveolar Lavage | 1 | 2022 | 89 | 0.050 |
Why?
| | Polymorphism, Genetic | 1 | 2025 | 612 | 0.050 |
Why?
| | Alkanesulfonic Acids | 1 | 2022 | 49 | 0.050 |
Why?
| | Mutation Rate | 1 | 2022 | 30 | 0.050 |
Why?
| | Pregnancy | 2 | 2025 | 7191 | 0.040 |
Why?
| | Chromatin | 1 | 2025 | 561 | 0.040 |
Why?
| | Bayes Theorem | 1 | 2023 | 433 | 0.040 |
Why?
| | Genome, Bacterial | 1 | 2022 | 156 | 0.040 |
Why?
| | Analysis of Variance | 1 | 2023 | 1311 | 0.040 |
Why?
| | Metabolomics | 1 | 2026 | 727 | 0.040 |
Why?
| | Mucin-5B | 1 | 2022 | 234 | 0.040 |
Why?
| | Multivariate Analysis | 1 | 2023 | 1540 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 442 | 0.040 |
Why?
| | Blood Pressure | 1 | 2025 | 1769 | 0.040 |
Why?
| | Cell Line, Tumor | 1 | 2025 | 3550 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2022 | 846 | 0.030 |
Why?
| | Pediatrics | 1 | 2024 | 1115 | 0.030 |
Why?
| | Risk Assessment | 1 | 2025 | 3676 | 0.030 |
Why?
| | DNA | 1 | 2022 | 1464 | 0.030 |
Why?
| | Diet | 1 | 2023 | 1275 | 0.030 |
Why?
| | Blood Glucose | 1 | 2025 | 2330 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2022 | 1982 | 0.030 |
Why?
| | Insulin | 1 | 2025 | 2507 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2025 | 5997 | 0.030 |
Why?
| | Cohort Studies | 1 | 2024 | 5965 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2023 | 1796 | 0.020 |
Why?
| | Prospective Studies | 1 | 2025 | 7997 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2024 | 6434 | 0.020 |
Why?
| | Aging | 1 | 2023 | 1966 | 0.020 |
Why?
| | Exercise | 1 | 2023 | 2201 | 0.020 |
Why?
| | Mutation | 1 | 2022 | 4099 | 0.020 |
Why?
| | Infant | 1 | 2024 | 10039 | 0.020 |
Why?
| | Child, Preschool | 1 | 2024 | 11799 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2020 | 8279 | 0.020 |
Why?
| | Mice | 1 | 2025 | 18365 | 0.020 |
Why?
| | Young Adult | 1 | 2021 | 14126 | 0.010 |
Why?
| | Animals | 1 | 2025 | 38109 | 0.010 |
Why?
|
|
Konigsberg's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|